Insmed Incorporated (NASDAQ:INSM) Q4 2025 Earnings Call Transcript February 19, 2026 Insmed Incorporated misses on earnings ...

When you sit too much, your brain function is compromised because there is less blood flow, which decreases the amount of oxygen that reaches the brain.

Transforming the chemicals industry, AI application models enhance formulation development, enabling rapid, accurate responses to evolving market demands.

You may feel relief and curiosity at once: new studies are narrowing how hormone therapy affects dementia risk, but the answer isn’t a simple yes or no. Evidence now suggests hormone therapy can ...

Over two years of research, the company analyzed more than 50 million physiological data points to formulate a regulation ...

Q4 2025 Earnings Call February 19, 2026 4:30 PM ESTCompany ParticipantsCaitlin Lowie - Vice President of Corporate Communications ...

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...

Depression is a complex and deeply personal experience. While almost everyone has periods of sadness, low mood or grief, depression is different. Major depressive disorder is persistent, interferes ...

DUSQ, a sleep science and recovery company, has raised ₹24 crore in seed funding led by Fireside Ventures, with participation ...

BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

No single ‘depression gene’ has been found, but large studies have identified over 100 genetic risk markers on chromosomes ...

Completed clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events and no viral rebounds with equivalent time to sustained symptom resolution; ...